Super Collagen Matrix (Type II)

by R & D Pharmaceutical · capsule · 60 capsules

  • On the market (NIH)
  • DSLD label 182528
  • Serving 1 capsule

Super Collagen Matrix (Type II) by R & D Pharmaceutical lists 2 ingredients, 2 with an amount per serving of 1 capsule, such as 1,000 mg of hydrolyzed type II collagen. Its current label entered the NIH Dietary Supplement Label Database on October 25, 2018.

What is in Super Collagen Matrix (Type II)?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Super Collagen Matrix (Type II): Supplement Facts rows against the market (DSLD label 182528, January 2026 release)
IngredientAmount% DVAmong products listing it
Hydrolyzed Type II CollagenHydrolyzed Type II Collagen Note: (10:1) (consists of)1,000 mgCollagen Peptides in Super Collagen Matrix (Type II) against 395 products1 g per serving; the middle half of products list 2.5 g to 11 g, the median 6 g.1 g

84% of 395 products listing collagen peptides give more (median 6 g). Per day at the most servings: 2 g.

Hyaluronic Acidas Rooster CombHyaluronic Acid (Form: extracted from Rooster Comb)100 mgHyaluronic acid in Super Collagen Matrix (Type II) against 900 products100 mg per serving; the middle half of products list 10 mg to 100 mg, the median 50 mg.100 mg

Higher than 64% of 900 products listing hyaluronic acid (median 50 mg). Per day at the most servings: 200 mg.

Source: NIH ODS Dietary Supplement Label Database, label 182528 (entered October 25, 2018), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with Super Collagen Matrix (Type II)'s, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Dosage: Take 1 capsule twice daily before meals or subjected to your physician's prescription
Warnings
Keep out of reach of children
Allergens and what it does not contain
This product does not contain artificial preservatives, artificial sweeteners, colors, flavors & sugar.
Storage
Storage: Store in a cool & dry place

Source: label statements in DSLD label 182528.

How many labels does Super Collagen Matrix (Type II) have?

One label is on file, entered on October 25, 2018.

  1. Label 182528 (current) Entered October 25, 2018 · on the market · 60 capsules

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names R & D Pharmaceutical Pte Ltd (distributor). All R & D Pharmaceutical products.

Where next?